Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 5 studies | 35% ± 7% |
Insufficient scRNA-seq data for expression of ENPP6 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 92% | 676.42 | 2430 / 2642 | 92% | 9.80 | 649 / 705 |
prostate | 89% | 288.32 | 217 / 245 | 58% | 1.87 | 293 / 502 |
kidney | 97% | 813.93 | 86 / 89 | 18% | 0.76 | 161 / 901 |
ovary | 98% | 993.92 | 176 / 180 | 17% | 0.57 | 71 / 430 |
spleen | 81% | 94.97 | 195 / 241 | 0% | 0 | 0 / 0 |
esophagus | 56% | 111.99 | 803 / 1445 | 13% | 0.41 | 24 / 183 |
bladder | 57% | 106.48 | 12 / 21 | 6% | 0.17 | 30 / 504 |
adrenal gland | 33% | 70.20 | 86 / 258 | 25% | 1.94 | 57 / 230 |
intestine | 54% | 71.72 | 517 / 966 | 4% | 0.08 | 23 / 527 |
breast | 36% | 50.85 | 164 / 459 | 16% | 0.38 | 180 / 1118 |
stomach | 28% | 31.65 | 101 / 359 | 8% | 0.26 | 22 / 286 |
uterus | 16% | 16.42 | 27 / 170 | 19% | 0.72 | 85 / 459 |
tonsil | 0% | 0 | 0 / 0 | 31% | 2.37 | 14 / 45 |
blood vessel | 28% | 40.71 | 370 / 1335 | 0% | 0 | 0 / 0 |
lung | 11% | 15.28 | 62 / 578 | 8% | 0.44 | 91 / 1155 |
thymus | 15% | 26.28 | 97 / 653 | 3% | 0.15 | 19 / 605 |
liver | 1% | 0.77 | 2 / 226 | 13% | 0.81 | 53 / 406 |
lymph node | 0% | 0 | 0 / 0 | 14% | 0.35 | 4 / 29 |
adipose | 12% | 18.71 | 148 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 0% | 0.46 | 1 / 328 | 12% | 0.22 | 21 / 178 |
skin | 2% | 1.21 | 28 / 1809 | 6% | 0.27 | 29 / 472 |
peripheral blood | 4% | 3.56 | 38 / 929 | 0% | 0 | 0 / 0 |
muscle | 4% | 3.11 | 30 / 803 | 0% | 0 | 0 / 0 |
heart | 1% | 0.83 | 11 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.01 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006629 | Biological process | lipid metabolic process |
GO_0019695 | Biological process | choline metabolic process |
GO_0046475 | Biological process | glycerophospholipid catabolic process |
GO_0098552 | Cellular component | side of membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0008889 | Molecular function | glycerophosphodiester phosphodiesterase activity |
GO_0047390 | Molecular function | glycerophosphocholine cholinephosphodiesterase activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0008081 | Molecular function | phosphoric diester hydrolase activity |
Gene name | ENPP6 |
Protein name | glycerophosphocholine cholinephosphodiesterase (EC 3.1.4.38) (Choline-specific glycerophosphodiester phosphodiesterase) (Ectonucleotide pyrophosphatase/phosphodiesterase family member 6) Alternative protein ENPP6 Glycerophosphocholine cholinephosphodiesterase ENPP6 (GPC-Cpde) (EC 3.1.4.-) (EC 3.1.4.38) (Choline-specific glycerophosphodiester phosphodiesterase) (Ectonucleotide pyrophosphatase/phosphodiesterase family member 6) (E-NPP 6) (NPP-6) |
Synonyms | UNQ1889/PRO4334 |
Description | FUNCTION: Choline-specific glycerophosphodiesterase that hydrolyzes glycerophosphocholine (GPC) and lysophosphatidylcholine (LPC) and contributes to supplying choline to the cells . Has a preference for LPC with short (12:0 and 14:0) or polyunsaturated (18:2 and 20:4) fatty acids. In vitro, hydrolyzes only choline-containing lysophospholipids, such as sphingosylphosphorylcholine (SPC), platelet-activating factor (PAF) and lysoPAF, but not other lysophospholipids (By similarity). . |
Accessions | ENST00000512353.1 ENST00000296741.7 D6R9P1 L8ECN5 Q6UWR7 |